XFJ-22495-74400
3 vaccinations
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 951 / CA
- Registered
- 2021-10-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-17
Dose 1 — Pfizer-BioNTech
-
2021-05-08
Dose 2 — Pfizer-BioNTech
-
2021-10-26
Registered in v-safe
- 2021-11-06
-
2021-11-18
Dose 3 — Pfizer-BioNTech
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-11-22
- 2021-11-23
-
2021-11-28
Survey response — day 7, dose 3MedDRA: Oropharyngeal pain — Feeling: FairFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2021-12-24
- 2021-12-30
- 2022-02-17
-
2022-05-20
Survey response — 6 months, dose 3MedDRA: Cough, Diarrhoea, Dyspnoea, Fatigue, Nausea, Oropharyngeal pain, Pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Cough, sore throat, chest congestion, nausea, diarrhea, shortness of breath, fatigue, body ache.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-20
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-24
- 2022-05-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-17 | Pfizer-BioNTech | No |
| 2 | 2021-05-08 | Pfizer-BioNTech | No |
| 3 | 2021-11-18 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-20 | Unsuccessful |
Free text
Release 10 — day 7, dose 3
Systemic reaction (other): Sore throat
Release 11 — 6 months, dose 3
Symptoms: Cough, sore throat, chest congestion, nausea, diarrhea, shortness of breath, fatigue, body ache.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release